drugset / Trial / NCT01448018
Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare ranibizumab injection to hemodilution at the early phase of Central Retinal Vein Occlusion (CRVO) and to determine if the combination of both treatments may have a synergic effect.
Timeline
- Start
- 2010-01
- Primary completion
- 2013-06
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | — | Intravitreal |